Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Galloway

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
British Medical Journal|July 17, 1976
Propranolol in hypertension: a dose-response studyD B Galloway, S C Glover, W G Hendry, et al.
British Medical Journal|July 17, 1976
Methyldopa and propranolol or practolol in moderate hypertensionJ C Petrie, D B Galloway, T A Jeffers, et al.
The Journal of Endocrinology|September 1, 1993
Effect of high-protein feed supplements on concentrations of growth hormone (GH), insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in plasma and on the amounts of GH and messenger RNA for GH in the pituitary glands of adult ramsI J Clarke, T P Fletcher, C C Pomares, et al.
British Journal of Clinical Pharmacology|March 1, 1985
Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonistP C O'Connor, J M Arnold, A N Brown, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
British Medical Journal|July 17, 1976
Propranolol in hypertension: a dose-response studyD B Galloway, S C Glover, W G Hendry, et al.
British Medical Journal|July 17, 1976
Methyldopa and propranolol or practolol in moderate hypertensionJ C Petrie, D B Galloway, T A Jeffers, et al.
The Journal of Endocrinology|September 1, 1993
Effect of high-protein feed supplements on concentrations of growth hormone (GH), insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in plasma and on the amounts of GH and messenger RNA for GH in the pituitary glands of adult ramsI J Clarke, T P Fletcher, C C Pomares, et al.
British Journal of Clinical Pharmacology|March 1, 1985
Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonistP C O'Connor, J M Arnold, A N Brown, et al.
Pageof 5